The Discounted Cash Flow (DCF) valuation of Aveo Pharmaceuticals Inc (AVEO) is (1,017.72) USD. With the latest stock price at 15.00 USD, the upside of Aveo Pharmaceuticals Inc based on DCF is -6884.8%.
Based on the latest price of 15.00 USD and our DCF valuation, Aveo Pharmaceuticals Inc (AVEO) is a sell. selling AVEO stocks now will result in a potential gain of 6884.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 8.8% | 7.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (4,283.76) - (580.47) | (1,017.72) |
| Upside | -28658.4% - -3969.8% | -6884.8% |